There were 1,491 press releases posted in the last 24 hours and 439,073 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Mateon and Oncotelic Complete Their Merger and Create a New Immuno-Oncology Company with a Late-Stage Clinical Asset Against Cancer and a Promising Product Pipeline

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image